Meitheal Prepares For Major US Injectables Push
Plans To Launch ‘Up To 20 New Products’ In 2024 Following Bupivacaine Introduction
Meitheal Pharmaceuticals says it is preparing to launch “up to 20 new products” this year in the US following a recent expansion of its generic injectables portfolio.
